Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Use of HA 330-II for Hemofiltration in Patients With ALF as a Bridge to Liver Transplantation .

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04243655
Recruitment Status : Recruiting
First Posted : January 28, 2020
Last Update Posted : January 28, 2020
Sponsor:
Information provided by (Responsible Party):
Asian Institute of Gastroenterology, India